Gregorich Zachery R, Peng Ying, Cai Wenxuan, Jin Yutong, Wei Liming, Chen Albert J, McKiernan Susan H, Aiken Judd M, Moss Richard L, Diffee Gary M, Ge Ying
Department of Cell and Regenerative Biology, University of Wisconsin-Madison , 1111 Highland Avenue, Madison, Wisconsin 53705, United States.
Molecular and Cellular Pharmacology Training Program, University of Wisconsin-Madison , 1111 Highland Avenue, Madison, Wisconsin 53705, United States.
J Proteome Res. 2016 Aug 5;15(8):2706-16. doi: 10.1021/acs.jproteome.6b00244. Epub 2016 Jul 13.
Sarcopenia, the loss of skeletal muscle mass and function with advancing age, is a significant cause of disability and loss of independence in the elderly and thus, represents a formidable challenge for the aging population. Nevertheless, the molecular mechanism(s) underlying sarcopenia-associated muscle dysfunction remain poorly understood. In this study, we employed an integrated approach combining top-down targeted proteomics with mechanical measurements to dissect the molecular mechanism(s) in age-related muscle dysfunction. Top-down targeted proteomic analysis uncovered a progressive age-related decline in the phosphorylation of myosin regulatory light chain (RLC), a critical protein involved in the modulation of muscle contractility, in the skeletal muscle of aging rats. Top-down tandem mass spectrometry analysis identified a previously unreported bis-phosphorylated proteoform of fast skeletal RLC and localized the sites of decreasing phosphorylation to Ser14/15. Of these sites, Ser14 phosphorylation represents a previously unidentified site of phosphorylation in RLC from fast-twitch skeletal muscle. Subsequent mechanical analysis of single fast-twitch fibers isolated from the muscles of rats of different ages revealed that the observed decline in RLC phosphorylation can account for age-related decreases in the contractile properties of sarcopenic fast-twitch muscles. These results strongly support a role for decreasing RLC phosphorylation in sarcopenia-associated muscle dysfunction and suggest that therapeutic modulation of RLC phosphorylation may represent a new avenue for the treatment of sarcopenia.
肌肉减少症是指随着年龄增长骨骼肌质量和功能的丧失,是老年人残疾和失去独立能力的重要原因,因此,对老龄化人口构成了巨大挑战。然而,肌肉减少症相关肌肉功能障碍的分子机制仍知之甚少。在本研究中,我们采用了一种综合方法,将自上而下的靶向蛋白质组学与力学测量相结合,以剖析与年龄相关的肌肉功能障碍的分子机制。自上而下的靶向蛋白质组学分析发现,在衰老大鼠的骨骼肌中,肌球蛋白调节轻链(RLC)的磷酸化水平随着年龄的增长而逐渐下降,RLC是一种参与调节肌肉收缩力的关键蛋白质。自上而下的串联质谱分析鉴定出一种以前未报道的快速骨骼肌RLC双磷酸化蛋白异构体,并将磷酸化水平降低的位点定位到Ser14/15。在这些位点中,Ser14磷酸化代表了快速抽搐骨骼肌RLC中一个以前未鉴定的磷酸化位点。随后对从不同年龄大鼠肌肉中分离出的单个快速抽搐纤维进行力学分析,结果表明,观察到的RLC磷酸化水平下降可以解释肌肉减少症快速抽搐肌肉收缩特性随年龄增长而下降的现象。这些结果有力地支持了RLC磷酸化水平降低在肌肉减少症相关肌肉功能障碍中的作用,并表明对RLC磷酸化进行治疗性调节可能是治疗肌肉减少症的一条新途径。